Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu, Feiran Wang, Chenguang Shen, et al.
Science (2020) Vol. 368, Iss. 6496, pp. 1274-1278
Open Access | Times Cited: 1069

Showing 1-25 of 1069 citing articles:

Characteristics of SARS-CoV-2 and COVID-19
Ben Hu, Hua Guo, Peng Zhou, et al.
Nature Reviews Microbiology (2020) Vol. 19, Iss. 3, pp. 141-154
Open Access | Times Cited: 4749
Coronavirus biology and replication: implications for SARS-CoV-2
Philip V’kovski, Annika Kratzel, Silvio Steiner, et al.
Nature Reviews Microbiology (2020) Vol. 19, Iss. 3, pp. 155-170
Open Access | Times Cited: 2794
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Tyler N. Starr, Allison J. Greaney, Sarah K. Hilton, et al.
Cell (2020) Vol. 182, Iss. 5, pp. 1295-1310.e20
Open Access | Times Cited: 2000
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Yunlong Cao, Jing Wang, Fanchong Jian, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 657-663
Open Access | Times Cited: 1734
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes, Claudia A. Jette, Morgan E. Abernathy, et al.
Nature (2020) Vol. 588, Iss. 7839, pp. 682-687
Open Access | Times Cited: 1659
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li, Jiajing Wu, Jianhui Nie, et al.
Cell (2020) Vol. 182, Iss. 5, pp. 1284-1294.e9
Open Access | Times Cited: 1549
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu, Pengfei Wang, Manoj S. Nair, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 450-456
Open Access | Times Cited: 1515
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi, Renhong Yan, Jun Zhang, et al.
Science (2020) Vol. 369, Iss. 6504, pp. 650-655
Open Access | Times Cited: 1483
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 1024-1042.e21
Open Access | Times Cited: 1438
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 1415
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna K. Hansen, Alina Baum, Kristen E. Pascal, et al.
Science (2020) Vol. 369, Iss. 6506, pp. 1010-1014
Open Access | Times Cited: 1339
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 443-449
Open Access | Times Cited: 1107
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, et al.
Cell Host & Microbe (2020) Vol. 29, Iss. 1, pp. 44-57.e9
Open Access | Times Cited: 1062
Viral targets for vaccines against COVID-19
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1050
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
Yixuan J. Hou, S. Chiba, Peter Halfmann, et al.
Science (2020) Vol. 370, Iss. 6523, pp. 1464-1468
Open Access | Times Cited: 955
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum, Anna De Marco, Florian A. Lempp, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2332-2347.e16
Open Access | Times Cited: 936
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
Lorenzo Casalino, Zied Gaieb, Jory A. Goldsmith, et al.
ACS Central Science (2020) Vol. 6, Iss. 10, pp. 1722-1734
Open Access | Times Cited: 930
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Mei-Yue Wang, Rong Zhao, Lijuan Gao, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 825
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Christopher O. Barnes, Anthony P. West, Kathryn E. Huey‐Tubman, et al.
Cell (2020) Vol. 182, Iss. 4, pp. 828-842.e16
Open Access | Times Cited: 823
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
Zhuoming Liu, Laura A. VanBlargan, Louis-Marie Bloyet, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 477-488.e4
Open Access | Times Cited: 809
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
Stephany Beyerstedt, Expedito Barbosa Casaro, Érika Bevilaqua Rangel
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 40, Iss. 5, pp. 905-919
Open Access | Times Cited: 716
COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. García-Beltrán, Evan C. Lam, Michael G. Astudillo, et al.
Cell (2020) Vol. 184, Iss. 2, pp. 476-488.e11
Open Access | Times Cited: 711
Neutralizing monoclonal antibodies for treatment of COVID-19
Peter C. Taylor, Andrew C. Adams, Matthew M. Hufford, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 6, pp. 382-393
Open Access | Times Cited: 706
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
Annette B. Vogel, Isis Kanevsky, Ye Che, et al.
Nature (2021) Vol. 592, Iss. 7853, pp. 283-289
Open Access | Times Cited: 633
Structural basis of a shared antibody response to SARS-CoV-2
Meng Yuan, Hejun Liu, Nicholas C. Wu, et al.
Science (2020) Vol. 369, Iss. 6507, pp. 1119-1123
Open Access | Times Cited: 628
Page 1 - Next Page

Scroll to top